skip to main content
Idioma:
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
An International Atherosclerosis Society Position Paper Global recommendations for the management of dyslipidemia Executive summary
An International Atherosclerosis Society Position Paper Global recommendations for the management of dyslipidemia Executive summary
Material Type:
Artigo 		Adicionar ao Meu Espaço

An International Atherosclerosis Society Position Paper Global recommendations for the management of dyslipidemia Executive summary

Scott M. Grundy Hidenori Arai; Philip Barter; Thomas P Bersot; D. John Betteridge; Rafael Carmena; Ada Cuevas; Michael H Davidson; Jacques Genesti; Y. Antero Kesäniemi; Shaukat Sadikot; Raul D Santos; Andrey Susekov; Rody Sy; Lale Tokgozoglu; Gerald F Watts; Dong Zhao

Atherosclerosis Amsterdam v. 232, n. 2, p. 410-413, 2014

Amsterdam 2014

Localização: FM - Fac. Medicina    (BCSEP 061 2014 )(Acessar)

2
An International Atherosclerosis Society Position Paper Global recommendations for the management of dyslipidemia-Full report
An International Atherosclerosis Society Position Paper Global recommendations for the management of dyslipidemia-Full report
Material Type:
Artigo 		Adicionar ao Meu Espaço

An International Atherosclerosis Society Position Paper Global recommendations for the management of dyslipidemia-Full report

Scott M. Grundy Hidenori Arai; Philip Barter; Thomas P Bersot; D. John Betteridge; Rafael Carmena; Ada Cuevas; Michael H Davidson; Jacques Genest; Y. Antero Kes€aniemi; Shaukat Sadikot; Raul D Santos; Andrey V Susekov; Rody G Sy; S LaleTokg€ozoglu; Gerald F Watts; Dong Zhao

Journal of clinical lipidology New York v. 8, n. 1, p. 29-60, 2014

New York 2014

Localização: FM - Fac. Medicina    (BCSEP 138 2014 )(Acessar)

3
HDL cholesterol level and mortality occurrence in the elderly [Editorial] is the good cholesterol always good?
HDL cholesterol level and mortality occurrence in the elderly [Editorial] is the good cholesterol always good?
Material Type:
Artigo 		Adicionar ao Meu Espaço

HDL cholesterol level and mortality occurrence in the elderly [Editorial] is the good cholesterol always good?

Raul Dias dos Santos Filho Philip J Barter

Journal of clinical endocrinology & metabolism v. 104, n. 9, p. 4114-4116, 2019

Washington 2019

Acesso online. A biblioteca também possui exemplares impressos.

4
Residual macrovascular risk in 2013 what have we learned?
Residual macrovascular risk in 2013 what have we learned?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Residual macrovascular risk in 2013 what have we learned?

Jean-Charles Fruchart Jean Davignon; Michel P Hermans; Khalid Al-Rubeaan; Pierre Amarenco; Gerd Assmann; Philip Barter; John Betteridge; Eric Bruckert; Ada Cuevas; Michel Farnier; Ele Ferrannini; Paola Fioretto; Jacques Genest; Henry N Ginsberg; Antonio M Gotto; Dayi Hu; Takashi Kadowaki; Tatsuhiko Kodama; Michel Krempf; Yuji Matsuzawa; Jesús Núñez-Cortés; Carlos Monfil; Hisao Ogawa; Jorge Plutzky; Daniel J Rader; Shaukat Sadikot; Raul D Santos; Evgeny Shlyakhto; Piyamitr Sritara; Rody Sy; Alan Tall; Chee Eng Tan; Lale Tokgözoğlu; Peter P Toth; Paul Valensi; Christoph Wanner; Alberto Zambon; Junren Zhu; Paul Zimmet

Cardiovascular Diabetology London v. 13, n. 26, 17 p. (on-line), 2014

London 2014

Acesso online. A biblioteca também possui exemplares impressos.

5
Problems of agricultural development
Material Type:
Livro 		Adicionar ao Meu Espaço

Problems of agricultural development

Philip George Haynes Barter

Genève Droz 1966

Localização: FEA - Fac. Econ. Adm. Contab. e Atuária  ACERVO DELFIM NETTO  (B11.1.44 )(Acessar)

6
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Material Type:
Artigo 		Adicionar ao Meu Espaço

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation

Jean-Charles Fruchart Raul Dias dos Santos Filho; Carlos Aguilar-salinas; Masanori Aikawa; Khalid Al Rasadi; Pierre Amarenco; Philip J Barter; Richard Ceska; Alberto Corsini; Jean-Pierre Despres

Cardiovascular diabetology v. 18, article ID 71, 20p, 2019

London 2019

Acesso online. A biblioteca também possui exemplares impressos.

7
Effects of dalcetrapib in patients with a recent acute coronary syndrome
Effects of dalcetrapib in patients with a recent acute coronary syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of dalcetrapib in patients with a recent acute coronary syndrome

Gregory G Schwartz Anders G Olsson; Markus Abt; Christie M Ballantyne; Philip J Barter; Jochen Brumm; Bernard R Chaitman; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J. V McMurray; Hardi Mundl; Stephen J Nicholls; Prediman K Shah; Jean-Claude Tardif; R. Scott Wright; Jose Antonio Marin Neto; The dal-OUTCOMES Investigators

The New England Journal of Medicine Boston v. 367, n. 22, p. 2089-2099, 2012

Boston 2012

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2400897 Estantes Deslizantes )(Acessar)

8
Effects of dalcetrapib in patients with a recent acute coronary syndrome
Effects of dalcetrapib in patients with a recent acute coronary syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of dalcetrapib in patients with a recent acute coronary syndrome

Gregory G Schwartz Anders G Olsson; Markus Abt; Christie M Ballantyne; Philip J Barter; Jochen Brumm; Bernard R Chaitman; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J. V McMurray; Hardi Mundl; Stephen J Nicholls; Prediman K Shah; Jean-Claude Tardif; R. Scott Wright; Jose Antonio Marin Neto; The dal-OUTCOMES Investigators

The New England Journal of Medicine Boston v. 367, n. 22, p. 2089-2099, 2012

Boston 2012

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2400897 Estantes Deslizantes )(Acessar)

9
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

A. Michael Lincoff Stephen J Nicholls; Jeffrey S Riesmeyer; Philip J Barter; H. Bryan Brewer; Keith A.A Fox; C. Michael Gibson; Christopher Granger; Venu Menon; Gilles Montalescot; Daniel Rader; Alan R Tall; Ellen McErlean; Kathy Wolski; Giacomo Ruotolo; Burkhard Vangerow; Govinda Weerakkody; Shaun G Goodman; Diego Conde; Darren K McGuire; Jose C Nicolau; Jose L Leiva-Pons; Yves Pesant; Weimin Li; David Kandath; Simon Kouz; Naeem Tahirkheli; Denise Mason; Steven E Nissen

The New England Journal of Medicine Boston v. 376, n. 20, p. 1933-1942, 2017

Boston 2017

Localização: FM - Fac. Medicina    (BCSEP 230 2017 )(Acessar)

Personalize Seus Resultados

  1. Editar

Refine Search Results

Mostrar Somente

  1. Recursos Online (3)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (8)
  2. Livros  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Barter, P
  2. Sadikot, S
  3. Sy, R
  4. Santos, R
  5. Cuevas, A

Neste Assunto:

  1. Doenças Cardiovasculares
  2. Dislipidemias
  3. Coronariopatia
  4. Fatores De Risco
  5. Colesterol

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.